Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Gadducci, R. Tana, G. Teti, Giulia Zanca, A. Fanucchi, A. Genazzani (2007)
Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancerInternational Journal of Gynecologic Cancer, 18
B. Asselin, J. Whitin, D. Coppola, I. Rupp, S. Sallan, H. Cohen (1993)
Comparative pharmacokinetic studies of three asparaginase preparations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 9
I. Otani, J. Wong, A. Banerji (2017)
Platinum Chemotherapy Hypersensitivity: Prevalence and Management.Immunology and allergy clinics of North America, 37 4
M. Markman, A. Kennedy, K. Webster, G. Peterson, B. Kulp, J. Belinson (1999)
An effective and more convenient drug regimen for prophylaxis gainst paclitaxel-associated hypersensitivity reactionsJournal of Cancer Research and Clinical Oncology, 125
M. Burke (2014)
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia.Future oncology, 10 16
Lynda Vrooman, J. Supko, D. Neuberg, B. Asselin, U. Athale, L. Clavell, K. Kelly, C. Laverdière, B. Michon, M. Schorin, H. Cohen, S. Sallan, L. Silverman (2010)
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 54
B. Baldo, M. Pagani (2014)
Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses.Immunology and allergy clinics of North America, 34 3
M. Nunzio, G. Perenlei, A. Douhal (2019)
Confinement Effect of Micro- and Mesoporous Materials on the Spectroscopy and Dynamics of a Stilbene Derivative DyeInternational Journal of Molecular Sciences, 20
R. Madrigal-Burgaleta, M. Berges-Gimeno, D. Angel-Pereira, R. Ferreiro-Monteagudo, C. Guillén-Ponce, C. Pueyo, E. Salazar, E. Álvarez-Cuesta (2013)
Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessmentAllergy, 68
S. Alsamarai, A. Charpidou, R. Matthay, Daniel Confeld, K. Syrigos, M. Saif (2009)
Pneumonitis related to docetaxel: case report and review of the literature.In vivo, 23 4
L. Goodman, M. Wintrobe, W. Dameshek, M. Goodman, A. Gilman, M. McLennan (1984)
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, WilJAMA, 251 17
M. Pagani, P. Bonadonna (2014)
Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin.Anticancer research, 34 1
E. Rowinsky, R. Donehower (1995)
Paclitaxel (taxol)The New England journal of medicine, 332 15
S. Akbayram, M. Dogan, C. Akgün, H. Çaksen, A. Öner (2010)
A Desensitization Protocol in Children With L-Asparaginase HypersensitivityJournal of Pediatric Hematology/Oncology, 32
J. Hou, M. Kelly, Herbert Yu, J. McAlpine, M. Azodi, T. Rutherford, P. Schwartz (2007)
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.Gynecologic oncology, 105 1
S. Patil, A. Long, M. Ling, M. Wilson, P. Hesterberg, J. Wong, A. Banerji (2012)
Food , drug , insect sting allergy , and anaphylaxis A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions
E. Jerschow, R. Lin, Moira Scaperotti, A. Mcginn (2014)
Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations.The Journal of allergy and clinical immunology, 134 6
Christina Lee, M. Gianos, W. Klaustermeyer (2009)
Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 102 3
M. Dilley, Joyce Lee, A. Broyles (2017)
Methotrexate hypersensitivity reactions in pediatrics: Evaluation and managementPediatric Blood & Cancer, 64
A. Polyzos, N. Tsavaris, C. Kosmas, T. Arnaouti, N. Kalahanis, C. Tsigris, A. Giannopoulos, G. Karatzas, L. Giannikos, P. Sfikakis (2001)
Hypersensitivity Reactions to Carboplatin Administration Are Common but Not Always Severe: A 10-Year ExperienceOncology, 61
J. Wong, M. Ling, S. Patil, A. Banerji, A. Long (2014)
Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.The journal of allergy and clinical immunology. In practice, 2 1
Leticia Sánchez, Leila Alenazy, Marlene Garcia-Neuer, M. Castells (2017)
Drug Hypersensitivity and Desensitizations: Mechanisms and New ApproachesInternational Journal of Molecular Sciences, 18
K. Sambasivan, S. Mahmoud, Arwa Kokache, M. Seckl, P. Savage (2014)
Hypersensitivity reactions to etoposide phosphateJournal of Oncology Pharmacy Practice, 20
J. Caiado, L. Venemalm, M. Pereira-Santos, L. Costa, M. Barbosa, M. Castells (2013)
Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.The journal of allergy and clinical immunology. In practice, 1 5
M. Castells, N. Tennant, D. Sloane, F. Hsu, N. Barrett, D. Hong, T. Laidlaw, H. Legere, Samridhi Nallamshetty, Ross Palis, J. Rao, S. Berlin, S. Campos, U. Matulonis
Food , drug , insect sting allergy , and anaphylaxis Hypersensitivity reactions to chemotherapy : Outcomes and safety of rapid desensitization in 413 cases
M. Pagani (2010)
The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.The Medical clinics of North America, 94 4
Gabriela Galindo-Rodríguez, J. Jaime-Pérez, M. Salinas-Carmona, S. González-Díaz, Ángeles Castro-Corona, Raúl Cavazos-González, Humberto Treviño-Villarreal, A. Heredia-Salazar, D. Gómez-Almaguer (2017)
Do immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional studyRevista Brasileira de Hematologia e Hemoterapia, 39
H. Hasan, O. Shaikh, S. Rassekh, A. Howard, K. Goddard (2017)
Comparison of hypersensitivity rates to intravenous and intramuscular PEG‐asparaginase in children with acute lymphoblastic leukemia: A meta‐analysis and systematic reviewPediatric Blood & Cancer, 64
J. Kuo, C. Hawkins, D. Yip (2015)
Application of hypersensitivity skin testing in chemotherapy-induced pneumonitisAsia Pacific Allergy, 5
V. Leguy-Seguin, G. Jolimoy, B. Coudert, C. Pernot, S. Dalac, Pierre Vabres, É. Collet (2007)
Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.The Journal of allergy and clinical immunology, 119 3
Nicholas Forcello, S. Khubchandani, Shrina Patel, Driola Brahaj (2015)
Oxaliplatin-induced immune-mediated cytopenias: A case report and literature reviewJournal of Oncology Pharmacy Practice, 21
E. Enrique, T. Malek, J. Castelló, J. Mateo (2008)
Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 100 1
N.Andrei Popescu, Michael Sheehan, Peter Kouides, John Loughner, J. Condemi, Richard Looney, J. Leddy (1996)
Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients.The Journal of allergy and clinical immunology, 97 1 Pt 1
N. Makrilia, E. Syrigou, I. Kaklamanos, L. Manolopoulos, M. Saif (2010)
Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic ReviewMetal-Based Drugs, 2010
J. Schwartz, C. Bandera, A. Bradley, L. Brard, R. Legare, C. Granai, D. Dizon (2007)
Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.Gynecologic oncology, 105 1
Fu-chao Chen, Lin-hai Wang, Xiaojun Zheng, Xiu-min Zhang, Jun Zhang, Lin-jun Li (2016)
Meta-analysis of the effects of oral and intravenous dexamethasone premedication in the prevention of paclitaxel-induced allergic reactionsOncotarget, 8
J. McAlpine, M. Kelly, D. O’Malley, M. Azodi, Karen Coombe, P. Schwartz, T. Rutherford (2006)
Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.Gynecologic oncology, 103 1
W. Stock, D. Douer, D. DeAngelo, M. Arellano, A. Advani, L. Damon, T. Kovacsovics, M. Litzow, M. Rytting, G. Borthakur, A. Bleyer (2011)
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelLeukemia & Lymphoma, 52
Melissa Hudson, Howard Weinstein, S Donaldson, Carol Greenwald, L. Kun, N. Tarbell, W. Humphrey, C. Rupp, Neyssa Marina, Judith Wilimas (1993)
Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 6
E. Tracey, B. Modi, R. Micheletti (2017)
Pemetrexed-Induced Pseudocellulitis Reaction With Eosinophilic Infiltrate on Skin Biopsy.The American Journal of dermatopathology, 39 1
H. Koshiba, K. Hosokawa, A. Kubo, Y. Miyagi, T. Oda, Y. Miyagi, A. Watanabe, H. Honjo (2009)
Incidence of Carboplatin-Related Hypersensitivity Reactions in Japanese Patients With Gynecologic MalignanciesInternational Journal of Gynecologic Cancer, 19
T. Iwamoto, H. Hirai, N. Yamaguchi, N. Kobayashi, H. Sugimoto, T. Tabata, M. Okuda (2014)
Carboplatin-induced severe hypersensitivity reaction: Role of IgE-dependent basophil activation and FcεRICancer Science, 105
E. Tham, Yew Cheng, M. Tay, A. Alcasabas, L. Shek (2015)
Evaluation and management of hypersensitivity reactions to chemotherapy agentsPostgraduate Medical Journal, 91
P. Souza, M. Friedlander, Cheryl Wilde, F. Kirsten, M. Ryan (1994)
Hypersensitivity Reactions to Etoposide: A Report of Three Cases and Review of the LiteratureAmerican Journal of Clinical Oncology, 17
Michael Berger, Leslie Dunlea, Amy Rettig, M. Lustberg, G. Phillips, C. Shapiro (2011)
Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reactionSupportive Care in Cancer, 20
G. Gastaminza, J. Borbolla, M. Goikoetxea, R. Escudero, J. Anton, J. Espinós, C. Lacasa, M. Fernández-Benítez, M. Sanz, M. Ferrer (2011)
A new rapid desensitization protocol for chemotherapy agents.Journal of investigational allergology & clinical immunology, 21 2
Chengcheng Liu, J. Kawedia, Cheng Cheng, Deqing Pei, C. Fernandez, Xiangjun Cai, K. Crews, S. Kaste, J. Panetta, W. Bowman, S. Jeha, J. Sandlund, W. Evans, C. Pui, M. Relling (2011)
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemiaLeukemia, 26
E. Syrigou, N. Makrilia, A. Vassias, I. Nikolaidis, V. Xyla, L. Manolopoulos, K. Syrigos (2010)
Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?Anti-Cancer Drugs, 21
P. Giavina-Bianchi, V. Galvão, M. Picard, J. Caiado, M. Castells (2017)
Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.The journal of allergy and clinical immunology. In practice, 5 3
M. Masse, D. Caimmi, P. Demoly (2012)
A delayed reaction to oxaliplatin.Journal of investigational allergology & clinical immunology, 22 5
S. Sliesoraitis, P. Chikhale (2004)
Carboplatin hypersensitivityInternational Journal of Gynecologic Cancer, 15
V. Mezzano, P. Giavina-Bianchi, M. Picard, J. Caiado, M. Castells (2014)
Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and ChemotherapyBioDrugs, 28
Wilson Mertens, Elizabeth Eisenhauer, Jacques Jolivet, S. Ernst, Malcolm Moore, A. Muldal (1994)
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.Annals of oncology : official journal of the European Society for Medical Oncology, 5 2
P. Demoly, Jean Bousquet (2002)
Drug allergy diagnosis work upAllergy, 57
P. Hesterberg, A. Banerji, Eyal Oren, R. Penson, C. Krasner, M. Seiden, J. Wong (2009)
Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.The Journal of allergy and clinical immunology, 123 6
M. Parel, F. Ranchon, A. Nosbaum, B. You, N. Vantard, V. Schwiertz, C. Gourc, N. Gauthier, M. Guédat, Sophie He, E. Kiouris, C. Alloux, T. Vial, V. Trillet‐Lenoir, G. Freyer, F. Bérard, C. Rioufol (2014)
Hypersensitivity to oxaliplatin: clinical features and risk factorsBMC Pharmacology & Toxicology, 15
G. Shepherd (2003)
Hypersensitivity reactions to chemotherapeutic drugsClinical Reviews in Allergy & Immunology, 24
O. Soyer, S. Aytaç, A. Tuncer, M. Çetin, S. Yetgin, B. Sekerel (2009)
Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.The Journal of allergy and clinical immunology, 123 4
M. Markman, K. Zanotti, G. Peterson, B. Kulp, K. Webster, J. Belinson (2003)
Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 24
Suna He, Zheng Cui, Xueqing Wang, Hua Zhang, Wenbing Dai, Qiang Zhang (2015)
Cremophor-free intravenous self-microemulsions for teniposide: Safety, antitumor activity in vitro and in vivo.International journal of pharmaceutics, 495 1
M. Picard, Leyla Pur, J. Caiado, P. Giavina-Bianchi, V. Galvão, S. Berlin, S. Campos, U. Matulonis, M. Castells (2016)
Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.The Journal of allergy and clinical immunology, 137 4
J. Patel, Lada Krilov, S. Adams, C. Aghajanian, E. Basch, M. Brose, W. Carroll, M. Lima, M. Gilbert, M. Kris, J. Marshall, G. Masters, S. O'Day, B. Polite, G. Schwartz, Sunil Sharma, I. Thompson, N. Vogelzang, B. Roth (2010)
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 2
P. Kintzel (2001)
Prophylaxis for Paclitaxel Hypersensitivity ReactionsAnnals of Pharmacotherapy, 35
T. Aoyama, M. Takano, M. Miyamoto, T. Yoshikawa, H. Soyama, Kento Kato, H. Ishibashi, H. Iwahashi, M. Nakatsuka, I. Yajima, Y. Shimizu, Y. Aizawa, Yuki Suguchi, Miki Moriiwa, T. Goto, H. Sasa, I. Nagaoka, H. Tsuda, K. Furuya (2017)
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?Cancer Chemotherapy and Pharmacology, 80
B. Rosenberg, L. Vancamp (1970)
The successful regression of large solid sarcoma 180 tumors by platinum compounds.Cancer research, 30 6
E. Álvarez-Cuesta, R. Madrigal-Burgaleta, D. Angel-Pereira, A. Ureña-Tavera, Miriam Zamora-Verduga, P. López-Gonzalez, M. Berges-Gimeno (2015)
Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitizationAllergy, 70
E. Syrigou, K. Syrigos, M. Saif (2008)
Hypersensitivity reactions to oxaliplatin and other antineoplastic agentsCurrent Allergy and Asthma Reports, 8
G. Masters, Lada Krilov, H. Bailey, M. Brose, H. Burstein, L. Diller, D. Dizon, H. Fine, G. Kalemkerian, M. Moasser, M. Neuss, S. O'Day, O. Odenike, Charles Ryan, R. Schilsky, G. Schwartz, A. Venook, S. Wong, J. Patel (2015)
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 7
J. Caiado, M. Picard (2014)
Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil MediatorsCurrent Allergy and Asthma Reports, 14
U. Narta, S. Kanwar, W. Azmi (2007)
Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.Critical reviews in oncology/hematology, 61 3
G. Brandi, M. Pantaleo, C. Galli, A. Falcone, A. Antonuzzo, P. Mordenti, M. Marco, G. Biasco (2003)
Hypersensitivity reactions related to oxaliplatin (OHP)British Journal of Cancer, 89
L. Goodman, M. Wintrobe, W. Dameshek, M. Goodman, A. Gilman, M. McLennan (1946)
NITROGEN MUSTARD THERAPY: Use of Methyl-Bis(Beta-Chloroethyl)amine Hydrochloride and Tris(Beta-Chloroethyl)amine Hydrochloride for Hodgkin's Disease, Lymphosarcoma, Leukemia and Certain Allied and Miscellaneous DisordersJAMA, 132
I. Ribeiro-Vaz, J. Marques, P. Demoly, J. Polónia, E. Gomes (2013)
Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance AuthorityEuropean Journal of Clinical Pharmacology, 69
R. Pieters, S. Hunger, J. Boos, C. Rizzari, L. Silverman, A. Baruchel, N. Goekbuget, M. Schrappe, C. Pui (2011)
L‐asparaginase treatment in acute lymphoblastic leukemiaCancer, 117
J. Cernadas, K. Brockow, A. Romano, W. Aberer, Marta Torres, A. Bircher, P. Campi, M. Sanz, M. Castells, P. Demoly, W. Pichler (2010)
General considerations on rapid desensitization for drug hypersensitivity – a consensus statementAllergy, 65
P. Schiff, J. Fant, S. Horwitz (1979)
Promotion of microtubule assembly in vitro by taxolNature, 277
C. Pui, L. Robison, A. Look (2008)
Acute lymphoblastic leukaemiaThe Lancet, 371
V. Avramis, Earl Avramis, William Hunter, M. Long (2009)
Immunogenicity of native or pegylated E. coli and Erwinia asparaginases assessed by ELISA and surface plasmon resonance (SPR-biacore) assays of IgG antibodies (Ab) in sera from patients with acute lymphoblastic leukemia (ALL).Anticancer research, 29 1
A. Schiavetti, G. Varrasso, P. Maurizi, M. Castello (1999)
Hypersensitivity to carboplatin in children.Medical and pediatric oncology, 32 3
M. Markman, A. Kennedy, K. Webster, B. Kulp, G. Peterson, J. Belinson (2000)
Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 1
M. Woo, Hak Lj, Storm Mc, W. Evans, W. Evans, J. Sandlund, J. Sandlund, G. Rivera, G. Rivera, Bo Wang, Pui Ch, Pui Ch, M. Relling, M. Relling (1998)
Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemiaLeukemia, 12
D. Dizon, P. Sabbatini, C. Aghajanian, M. Hensley, D. Spriggs (2002)
Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.Gynecologic oncology, 84 3
J. Caiado, M. Castells (2015)
Presentation and Diagnosis of Hypersensitivity to Platinum DrugsCurrent Allergy and Asthma Reports, 15
M. Castells (2015)
Anaphylaxis to chemotherapy and monoclonal antibodies.Immunology and allergy clinics of North America, 35 2
John Olson, A. Sood, J. Sorosky, B. Anderson, R. Buller (1998)
Taxol hypersensitivity: rapid retreatment is safe and cost effective.Gynecologic oncology, 68 1
P. Giavina-Bianchi, S. Patil, A. Banerji (2017)
Immediate Hypersensitivity Reaction to Chemotherapeutic Agents.The journal of allergy and clinical immunology. In practice, 5 3
G. Genestreti, M. Battista, R. Trisolini, Fabio Denicolò, M. Valli, L. Lazzari-Agli, Giorgia Piaz, D. Biase, M. Bartolotti, G. Cavallo, A. Brandes (2015)
A Commentary on Interstitial Pneumonitis Induced by Docetaxel: Clinical Cases and Systematic Review of the LiteratureTumori Journal, 101
D. Moon, J. Lee, A. Noonan, C. Annunziata, L. Minasian, N. Houston, J. Hays, E. Kohn (2013)
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactionsBritish Journal of Cancer, 109
D. Josephs, D. Josephs, J. Spicer, C. Corrigan, H. Gould, S. Karagiannis (2013)
Epidemiological associations of allergy, IgE and cancerClinical & Experimental Allergy, 43
M. Pagani, L. Venemalm, Patrizia Bonnadona, P. Vescovi, C. Botelho, J. Cernadas (2012)
An experimental biological test to diagnose hypersensitivity reactions to carboplatin: new horizons for an old problem.Japanese journal of clinical oncology, 42 4
E. Rowinsky, R. Donehower (1995)
Drug therapy : paclitaxel (Taxol)The New England Journal of Medicine, 332
Gastric ULCERAnON, gastric ulcer (1975)
Clinical OncologyWest of England Medical Journal, 107
E. Han, B. Monk (2007)
What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?Gynecologic oncology, 105 1
M. Callahan, J. Lachance, R. Stone, J. Kelsey, L. Rice, A. Jazaeri (2007)
Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer.American journal of obstetrics and gynecology, 197 2
R. Gomez, P. Harter, H. Lück, A. Traut, S. Kommoss, M. Kandel, A. Bois (2009)
Carboplatin Hypersensitivity: Does Introduction of Skin Test and Desensitization Reliably Predict and Avoid the Problem? A Prospective Single-Center StudyInternational Journal of Gynecologic Cancer, 19
A. Feldweg, Chyh-Woei Lee, U. Matulonis, M. Castells (2005)
Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.Gynecologic oncology, 96 3
A. Wang, S. Patil, A. Long, A. Banerji (2015)
Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 115 5
T. André, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, T. Hickish, C. Topham, M. Zaninelli, P. Clingan, J. Bridgewater, I. Tabah-Fisch, A. Gramont (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.The New England journal of medicine, 350 23
Maurie Markman, A. Kennedy, K. Webster, P. Elson, G. Peterson, B. Kulp, J. Belinson (1999)
Clinical features of hypersensitivity reactions to carboplatin.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 4
Curr Treat Options Allergy (2018) 5:118–132 DOI 10.1007/s40521-018-0160-x Drug Allergy (MJ Torres Jaén, Section Editor) Options in Hypersensitivity Reactions to Chemotherapeutics Mauro Pagani Address Medical Department ASST di Mantova, Presidio Ospedaliero di Pieve di Coriano, Via Bugatte, 1 Pieve di Coriano, 46024, Mantova, Italy Email: mauro.pagani@asst-mantova.it Published online: 30 January 2018 * Springer International Publishing AG, part of Springer Nature 2018 This article is part of the Topical Collection on Drug Allergy Keywords Chemotherapy hypersensitivity Drug allergy Platinum compound hypersensitivity I I I Taxane hypersensitivity Asparaginase hypersensitivity Desensitization I I Opinion statement Purpose of review Chemotherapeutic drugs still represent a gold standard for the treatment of neoplastic disease. They can induce hypersensitivity reactions and are the third leading cause of fatal drug-induced anaphylaxis in the USA. This article has tried to highlight and summarize the most recent scientific progress concerning risk factors, pathogenesis, diagnosis, and treatment of these reactions. Recent findings Identification of patients at high risk of developing hypersensitivity reactions allows risk stratification to guide clinical decision-making. Therefore, the most recent researches evaluated the possibility to perform risk stratification in case of hypersensitivity reactions to platinum compounds and taxanes. In addition, new data are now available regarding the
Current Treatment Options in Allergy – Springer Journals
Published: Jan 30, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.